OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
38
Results
Show all
Save search
Copy query
Show results for
Unknown
(38)
Publication Date
Release Date
2023
(8)
2021
(7)
2022
(4)
2025
(3)
2024
(3)
2020
(3)
2018
(2)
2005
(2)
2004
(2)
2019
(1)
2017
(1)
2009
(1)
2007
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Grading Ductal Carcinoma In Situ (DCIS) of the Breast - What's Wrong with It?
Not available
S-EPMC7242244
|
biostudies-literature
Cite
Prognostic value of histopathology and trends in cervical cancer: a SEER population study.
Not available
S-EPMC1994954
|
biostudies-literature
Cite
The additional value of ONEST (Observers Needed to Evaluate Subjective Tests) in assessing reproducibility of oestrogen receptor, progesterone receptor, and Ki67 classification in breast cancer.
Not available
S-EPMC8724065
|
biostudies-literature
Cite
Examination of Tumor Regression Grading Systems in Breast Cancer Patients Who Received Neoadjuvant Therapy.
Not available
S-EPMC7471177
|
biostudies-literature
Cite
Minimum follow-up time required for the estimation of statistical cure of cancer patients: verification using data from 42 cancer sites in the SEER database.
Not available
S-EPMC1164404
|
biostudies-literature
Cite
The prognostic value of stem cell markers in triple-negative breast cancer.
Not available
S-EPMC10766821
|
biostudies-literature
Cite
The kisspeptin-1 receptor antagonist peptide-234 aggravates uremic cardiomyopathy in a rat model.
Not available
S-EPMC10462750
|
biostudies-literature
Cite
Lobular Breast Cancer: Histomorphology and Different Concepts of a Special Spectrum of Tumors.
Not available
S-EPMC8345067
|
biostudies-literature
Cite
Comparison of the antiremodeling effects of losartan and mirabegron in a rat model of uremic cardiomyopathy.
Not available
S-EPMC8410807
|
biostudies-literature
Cite
Architectural Grade Combined With Spread Through Air Spaces (STAS) Predicts Recurrence and is Suitable for Stratifying Patients Who Might Be Eligible for Lung Sparing Surgery for Stage I Adenocarcinomas.
Not available
S-EPMC7471099
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets